Latest News and Press Releases
Want to stay updated on the latest news?
-
VENU (NYSE American: VENU) has $1 billion in construction already underway and a projected $5 billion in new venue development over the next 36 months
-
ThinkEquity upgrades VENU (NYSE American: VENU) with a Buy rating and an $18 price target
-
Providence, RI, May 01, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development and commercialization of scientifically compelling...
-
NEW YORK, June 07, 2022 (GLOBE NEWSWIRE) -- AnaChart, an innovative Fintech startup company, is exiting its stealth mode with an intent to disrupt the equity research industry. AnaChart democratizes...
-
Holbrook, New York, May 17, 2021 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC Pink: EMOR) (“Healixa”, or the “Company”), a healthcare technology company delivering seamless and instant virtual care from...